Clinical Trial: Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891312) titled 'Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery' on Oct. 15.

Brief Summary: This study is a randomized controlled clinical trial focusing on the prevention of postoperative nausea and vomiting (PONV), planned to start in May 2026 and end in April 2027. It primarily compares the efficacy and safety of amisulpride injection combined with ondansetron versus ondansetron alone in patients undergoing laparoscopic surgery. A centralized stratified block randomization method will be used. In the combination group, patients will receive a single intravenous injection o...